Skip to main content

NORGES BANK

Bank

Position in DYN — Dyne Therapeutics, Inc.

CIK 1374170 OSLO, Q8

Position in DYN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$1,095,374
+$130,695 QoQ
Shares Held
49,319
0.0% QoQ
Ownership
0.026%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#119
of 245 holders
Holding Since
Sep 2020
18 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in DYN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NORGES BANK holds $7,365,469,141 across 55 Biotechnology names. DYN ranks #50 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DYN

Export CSV
18 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,095,374 49,319
2025-12-31 $964,679 49,319
2025-06-30 $469,516 49,319
2025-03-31 $1,149,784 109,922
2024-12-31 $22,384,450 950,104
2024-09-30 $15,529,185 432,327
2024-06-30 $3,779,170 107,089
2024-03-31 $1,341,654 47,258
2023-06-30 $2,200,500 195,600
2023-03-31 $4,188,672 363,600
2022-12-31 $1,828,345 157,752
2022-03-31 $5,784,000 600,000
2021-12-31 $8,363,426 703,400
2021-09-30 $11,645,704 717,100
2021-06-30 $12,624,000 600,000
2021-03-31 $9,318,000 600,000
2020-12-31 $8,400,000 400,000
2020-09-30 $9,706,726 480,769